Introduction to CGT Beyond CAR T-Cell Therapy for Statisticians and Data Scientists
Conference: ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop 2024
09/26/2024: 1:15 PM - 2:30 PM EDT
Parallel
CAR T-cell therapy is used as a motivating example in many cases. However, there are a multitude of other cell and gene therapies that bring their own considerations. In this session, we will briefly introduce other types of cell and gene therapies, for example NK cell therapies, AAV gene therapy and gene editing technology, that may have different manufacturing, administration, toxicity profiles, and long term follow up requirements. Statisticians and data scientists should have keen awareness of the aspects of various therapies to be best equipped to serve and advise in our roles. We will also briefly highlight the study designs that have been used historically.
cell therapy
gene therapy
cell and gene therapy
CGT
Presenting Author
James Whitmore, Kite Pharma
You have unsaved changes.